The limits of disclosure: What research subjects want to know about investigator financial interests

Journal of Law, Medicine and Ethics

Volumn 34, Issue 3, 2006, Pages 592-599

  Grady, Christine ^a   Horstmann, Elizabeth ^b   Sussman, Jeffrey S ^c   Hull, Sara Chandros ^d,e  

^a Clinical Center   (United States)

^b NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^c BRANDEIS UNIVERSITY   (United States)

^d NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATTITUDE TO HEALTH; CONFERENCE PAPER; CONFLICT OF INTEREST; DECISION MAKING; ECONOMICS; ETHICS; FINANCIAL MANAGEMENT; HUMAN; HUMAN EXPERIMENT; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; INTERVIEW; MEDICAL RESEARCH; PROFESSIONAL STANDARD; PSYCHOLOGICAL ASPECT; QUALITATIVE RESEARCH; RESEARCH SUBJECT; TRUST; UNITED STATES;

ATTITUDE TO HEALTH; BIOMEDICAL RESEARCH; CONFLICT OF INTEREST; DECISION MAKING; DISCLOSURE; ETHICS COMMITTEES, RESEARCH; HUMANS; INFORMED CONSENT; INTERVIEWS; INTERVIEWS AS TOPIC; QUALITATIVE RESEARCH; RESEARCH SUBJECTS; RESEARCH SUPPORT; RESEARCH SUPPORT AS TOPIC; THERAPEUTIC HUMAN EXPERIMENTATION; TRUST; UNITED STATES;

EID: 33749413756     PISSN: 10731105     EISSN: 1748720X     Source Type: Journal    
DOI: 10.1111/j.1748-720X.2006.00073.x     Document Type: Conference Paper

References (27)

1. T. Bodenheimer, "Uneasy Alliance - Clinical Investigators and the Pharmaceutical Industry," N. Engl. J. Med. 342, no. 20 (2000): 1539-1544;
2. T. D. Warner, J. P. Gluck, "What do we Really Know about Conflicts of Interest in Biomedical Research?" Psychopharmacology (Berl) 171, no.1 (2003): 36-46;
3. J. E. Bekelman, Y. Li, C. P. Gross, "Scope and Impact of Financial Conflicts of Interest in Biomedical Research," JAMA 289 (2003): 454-465;
4. H. Moses, E. Dorsey, D. Matheson, S. Their, "Financial Anatomy of Biomedical Research," JAMA 294 (2005): 1333-1342.
5. E. A. Boyd, L. A. Bero, "Assessing Faculty Financial Relationships with Industry: A Case Study," JAMA 284 (2000): 2209-2214;
6. D. Blumenthal, et al., "Participation of Life-Science Faculty in Research Relationships with Industry,"N. Engl. J. Med 335 (1996): 1734-1739;
7. S. Krimsky, et al., "Financial Interests of Authors in Scientific Journals : A Pilot Study of 14 Publications," Science and Engineering Ethics 2, no. 4 (1996): 395-410.
8. See Warner and Gluck, supra note 1.
9. B. Djulbegovic, et al., "The Uncertainty Principle and Industry-Sponsored Research," Lancet 356, no. 9230 (2000): 635-638;
10. L. L. Kjaergard and B. Als-Nielsen, "Association between Competing Interests and Authors's Conclusions: Epidemiological Study of Randomized Clinical Trials Published in the BMJ," British Medical Journal 325, no. 7358 (2002): 249;
11. D. E. Barnes and L. A. Bero, "Why Review Articles on the Health Effects of Passive Smoking Reach Different Conclusions," JAMA 279 (1998): 1566-1570;
12. L. S. Friedman, E. D. Richter, "Relationship between Conflicts of Interest and Research Results," Journal of General Internal Medicine 19, no. 1 (2004): 51-56.
13. L. Andrews, "Money is Putting People at Risk in Biomedical Research," Chronicle of Higher Education 46, no. 27 (2000): B1, B4-5.
14. R. Smith, "Beyond Conflict of Interest: Transparency is the Key," British Medical Journal 317 (7154) (1998): 291-292;
15. Association of American Medical Colleges (AAMC), Protecting Subjects, Preserving Trust, Promoting Progress II: Principles and Recommendations for Oversight of an Institution's Financial Interests in Human Research (Washington, DC: AAMC, 2002);
16. D. Resnik, Disclosing Conflicts of Interest to Research Subjects: An Ethical and Legal Analysis," Accountability in Research 11 (2004): 141-159.
17. D. Thomspon, "Understanding Financial Conflicts of Interest," N. Engl. J. Med. 329 (1993): 573-576.
18. S. Krimsky, L. S. Rothenberg, "Financial Interest and its Disclosure in Scientific Publications," JAMA 280, no. 3 (1998): 225-226;
19. B. Brody, C. Anderson, S. Van McCrary, L. McCullough, R. Morgan, N. Wray, "Expanding Disclosure of Conflicts of Interest: The Views of Stakeholders," IRB Ethics and Human Research 25, no.1 (2003): 1-8.
20. S. V. McCrary, C. B. Anderson, B. S. Jakovljevic, T. Khan, L. Mc-Cullough, N. Wray, B. Brody, "A National Survey of Policies on Disclosure of Conflicts of Interests in Biomedical Research," N. Engl. J. Med. 342 (2000): 1621-1626;
21. DHHS Final Guidance, Financial Relationships and Interest in Research with Human Subjects, 2003, available at 〈http://www.hhs.gov/ohrp/policy/index.html#topics〉 (last visited March 24, 2006);
22. K. Weinfurt, M. Dinan, J. Allsbrook, J. Friedman, M. Hall, K. Schulman, J. Sugarman, "Policies of Academic Medical Centers for Disclosing Financial Conflicts of Interest to Potential Research Participants," Academic Medicine 81, no. 2 (2006): 113-118.
23. J. La Puma, C. Stocking, W. Rhoades, C. Darling, R. Ferner, J. Neuberger, M. VandenBurg, I. Dews, J. Tobias, "Financial Ties as Part of Informed Consent to Postmarketing Research: Attitudes of American Doctors and Patients," British Medical Journal 310 (1995): 1660-1663;
24. S. Y. Kim, R. Millard, P. Nisbet, C. Cox, E. Caine, "Potential Research Participants' Views Regarding Researcher and Institutional Financial Conflicts of Interest," Journal of Medical Ethics 30 (2004): 73-79.
25. See S. Y. Kim, et al., supra note 10.
26. Easter Cooperative Oncology Group, ECOG Performance Status, available at 〈http://www.ecog.org/general/perf_stat.html〉 (last visited March 24, 2006).
27. See D. Thompson, supra note 7, at 576.